By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
This deep dive focuses on the value of ePROs in managing immune-related adverse effects and the impact this has on patient wellbeing and outcomes. It also considers the value and potential of the real-world data collected within the context of patients’ environments, and how this longitudinal view of patient wellbeing and treatment progression gives pharma companies a competitive advantage within the market.
